09 February 2017: Sysmex Enters into Cancer and Rare Diseases Research Collaboration Agreement with the University of Tokyo

Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) and the University of Tokyo (Location: Bunkyo-ku, Tokyo; President: Makoto Gonokami) have entered into a research collaboration agreement involving the development of a target gene panel1. The objective is to analyze lung cancer, sarcoma and other specified types of diseases, and analyze genetic mutations related to rare diseases2 with a view to the clinical application of genomic medicine.

08 February 2017: Nelson Marlborough joins South Island shared electronic medical record

Clinicians at Nelson Marlborough District Health Board now have access to diagnostic test results and other clinical documents stored the South Island’s shared Eclair clinical data repository, following the recent implementation of the Health Connect South clinical information portal. The go live of the system at NMDHB means that all five South Island DHBs are […]

Please let us know your opinion of our Health IT Resources section

Were the resources provided useful?

What other health IT or scientific topics would you be interested in reading?

close